ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE5237.50-13.7 (-0.26 %)
PREV CLOSE ( ) 5251.20
OPEN PRICE ( ) 5273.35
BID PRICE (QTY) 5227.55 (1)
OFFER PRICE (QTY) 5235.05 (2)
VOLUME 163
TODAY'S LOW / HIGH ( )5183.30 5281.50
52 WK LOW / HIGH ( )4409.9 6440
NSE5233.70-22.15 (-0.42 %)
PREV CLOSE( ) 5255.85
OPEN PRICE ( ) 5260.65
BID PRICE (QTY) 5233.60 (4)
OFFER PRICE (QTY) 5233.70 (57)
VOLUME 44497
TODAY'S LOW / HIGH( ) 5183.50 5285.00
52 WK LOW / HIGH ( )4407.05 6439.9
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.